和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02256 和誉-B

休市中 10-23 16:08:09

6.915

-0.120

-1.71%

最高7.350	最低6.765	成交量75.79万
今开7.000	昨收7.035	日振幅8.32%
总市值49.51亿	流通市值49.51亿	总股本7.16亿
成交额524.06万	换手率0.11%	流通股本7.16亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02256","market":"HK","secType":"STK","nameCN":"和誉-B","latestPrice":6.915,"timestamp":1792742889003,"preClose":7.035,"halted":0,"volume":757897,"delay":0,"changeRate":-0.01705756929637528,"floatShares":716000000,"shares":716000000,"eps":0.088442,"marketStatus":"休市中","change":-0.12,"latestTime":"10-23 16:08:09","open":7,"high":7.35,"low":6.765,"amount":5240643,"amplitude":0.083156,"askPrice":6.915,"askSize":2000,"bidPrice":6.9,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.749,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":7,"adr":0,"listingDate":1634054400000,"exchange":"SEHK","adjPreClose":7.035,"openAndCloseTimeList":[[1792719000000,1792728000000],[1792731600000,1792742400000]],"volumeRatio":0.40568969876163913,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02256/","defaultTab":"news","newsList":[{"id":"1110862542","title":"和誉-B回购8万股股份，总额约55.47万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110862542","media":"公告速递","labels":[],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110862542?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:07","pubTimestamp":1792750029,"startTime":"0","endTime":"0","summary":"2026年10月23日，和誉开曼有限责任公司发布翌日披露报表，宣布于2026年10月23日于香港联交所场内回购公司股份8万股，占交易前已发行股本约0.01117%。本次回购的每股价格介于每股6.84港元至7.35港元之间，合计付出对价约55.47万港元。回购完成后，公司已发行股本由716,347,350股降至716,267,350股，库藏股数相应由9,858,000股增至9,938,000股，合计股份总数维持726,205,350股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"和誉-B回购8万股股份，总额约55.47万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677928161","title":"和誉-B(02256.HK)10月23日斥资55.47万港元回购8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677928161","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677928161?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:03","pubTimestamp":1792749825,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","BK1161","LU2476274720.SGD","LU2488822045.USD","IE00B543WZ88.USD","02256","LU2778985437.USD","LU2476274308.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159290156","title":"和誉-B：10月21日回购5万股，耗资约37.62万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159290156","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159290156?lang=zh_cn&edition=full","pubTime":"2026-10-21 21:06","pubTimestamp":1792587968,"startTime":"0","endTime":"0","summary":"2026年10月21日，和誉开曼有限责任公司发布翌日披露报表，公布公司于香港联合交易所有限公司场内进行的股份回购情况。公告显示，和誉-B于2026年10月21日回购普通股股份50,000股，占回购前已发行股本约0.00698%。回购价格区间介乎每股港币7.49元至7.55元，合计动用资金约37.62万港元。公司确认，此次回购已获董事会正式批准，并严格遵守香港联交所证券上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"和誉-B：10月21日回购5万股，耗资约37.62万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677746256","title":"和誉-B(02256)10月21日斥资37.62万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2677746256","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677746256?lang=zh_cn&edition=full","pubTime":"2026-10-21 21:05","pubTimestamp":1792587917,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年10月21日斥资37.62万港元回购5万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510382.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","BK1161","LU2476274720.SGD","LU2488822045.USD","IE00B543WZ88.USD","02256","LU2778985437.USD","LU2476274308.USD","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172063689","title":"和誉-B：自主创新药Lavengratinib获欧盟孤儿药资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1172063689","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172063689?lang=zh_cn&edition=full","pubTime":"2026-10-21 12:06","pubTimestamp":1792555584,"startTime":"0","endTime":"0","summary":"此次获批孤儿药资格，是Lavengratinib国际化开发的又一关键里程碑。\\n\\n公告显示，Lavengratinib此前已获美国食品药品监督管理局授予治疗ACH的孤儿药资格及罕见儿科疾病资格，并已通过FDA的临床试验  申请。\\n\\nLavengratinib是全球首个进入临床试验的FGFR2/3选择性抑制剂，采用直径小于3毫米的口服微片制剂，旨在提升长期用药的便利性和依从性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677164143","title":"和誉-B(02256)：和誉医药Lavengratinib (ABSK061) 用于治疗软骨发育不全获EMA授予孤儿药资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2677164143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677164143?lang=zh_cn&edition=full","pubTime":"2026-10-21 12:04","pubTimestamp":1792555473,"startTime":"0","endTime":"0","summary":"此前，lavengratinib治疗ACH适应症已获得美国食品药品监督管理局授予的孤儿药资格及罕见儿科疾病资格，其IND申请已获FDA批准。目前，和誉医药正在积极推进lavengratinib治疗3至12岁ACH儿童的II期、多中心、开放标签的剂量递增研究。近期公布的初步数据显示，lavengratinib展现出积极的促生长信号，且总体安全性和耐受性良好。和誉医药将持续推进lavengratinib用于ACH治疗的全球临床开发，进一步评估其安全性和有效性，并探索其为全球ACH儿童患者提供新的治疗选择的潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1509966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK1574","09939","159938","02256","IE00BPRC5H50.USD","LU2476274308.USD","LU2488822045.USD","LU2778985437.USD","LU2476274720.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165798379","title":"和誉-B 10月20日回购6万股股份，总额约45.65万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1165798379","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165798379?lang=zh_cn&edition=full","pubTime":"2026-10-20 18:36","pubTimestamp":1792492576,"startTime":"0","endTime":"0","summary":"和誉开曼有限责任公司于2026年10月20日发布公告称，公司当日通过香港联交所场内回购普通股60,000股，占前一交易日公司已发行股本的约0.00837%。本次回购价格区间为每股7.505港元至7.64港元，合计耗资约45.65万港元。回购完成后，截至2026年10月20日收市，公司已发行股份减少至716,397,350股，库存股份增加至9,808,000股，总已发行股份数维持726,205,350股。公司同时披露，回购授权于2026年5月20日获批，可回购股份总数为71,646,135股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"和誉-B 10月20日回购6万股股份，总额约45.65万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676662917","title":"和誉-B(02256.HK)10月20日斥资45.65万港元回购6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2676662917","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676662917?lang=zh_cn&edition=full","pubTime":"2026-10-20 18:33","pubTimestamp":1792492414,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","LU2488822045.USD","LU2476274308.USD","IE00BPRC5H50.USD","IE00B543WZ88.USD","LU2476274720.SGD","LU2778985437.USD","02256","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193118703","title":"和誉-B：10月15日回购5万股股份，耗资约36.16万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193118703","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193118703?lang=zh_cn&edition=full","pubTime":"2026-10-15 18:56","pubTimestamp":1792061794,"startTime":"0","endTime":"0","summary":"2026年10月15日，和誉开曼有限责任公司于香港联交所发布翌日披露报表，公告当日回购普通股50,000股，约占本次回购前已发行股份总数的0.00698%。本次回购的每股价格介乎每股7.185港元至7.29港元，合计支付约36.16万港元。回购完成后，公司已发行股份数量变为716,457,350股，库藏股数量增至9,748,000股。公告同时显示，公司已于2026年5月20日获股东大会授予回购股份的授权，总可回购股份数为71,646,135股。公司确认已遵守香港联交所证券上市规则及相关法律法规的要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B：10月15日回购5万股股份，耗资约36.16万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112035091","title":"和誉-B回购5万股股份，总额约37.19万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112035091","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112035091?lang=zh_cn&edition=full","pubTime":"2026-10-14 19:20","pubTimestamp":1791976854,"startTime":"0","endTime":"0","summary":"和誉开曼有限责任公司于2026年10月14日发布翌日披露报表，披露公司当日通过香港联交所场内回购普通股5万股，约占回购前已发行股本的0.00698%。其中，回购价格区间介乎每股7.39港元至7.46港元，合计涉资约37.19万港元。购回授权于2026年5月20日获得批准，可回购股份总数71,646,135股，公司已累计回购1,954,000股。公司确认本次回购已遵守香港联交所《主板上市规则》及相关法律法规，并已根据相关规定履行必要审批及手续。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"和誉-B回购5万股股份，总额约37.19万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675175346","title":"和誉-B(02256.HK)10月14日斥资37.19万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675175346","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675175346?lang=zh_cn&edition=full","pubTime":"2026-10-14 19:19","pubTimestamp":1791976772,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02256","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU2476274720.SGD","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","LU2476274308.USD","LU2778985437.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148936265","title":"和誉-B10月8日回购5万股，涉资约40.93万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1148936265","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148936265?lang=zh_cn&edition=full","pubTime":"2026-10-08 19:42","pubTimestamp":1791459731,"startTime":"0","endTime":"0","summary":"和誉-B于2026年10月8日发布翌日披露报表，公告显示公司于当日通过香港联交所场内回购普通股5万股，占回购前已发行股本约0.00698%。本次回购每股价格介乎8.135港元至8.235港元，合计耗资409,275港元，即约40.93万港元。回购授权于2026年5月20日经股东大会表决通过，授权最高可回购71,646,135股。公司确认已严格遵守香港联交所证券上市规则及相关法律法规开展上述回购。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B10月8日回购5万股，涉资约40.93万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673006071","title":"和誉-B(02256.HK)10月8日斥资40.93万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673006071","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673006071?lang=zh_cn&edition=full","pubTime":"2026-10-08 19:41","pubTimestamp":1791459678,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B543WZ88.USD","LU2476274308.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU2488822045.USD","BK1161","LU2778985437.USD","02256","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673940820","title":"和誉-B(02256)10月7日斥资26.02万港元回购3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673940820","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673940820?lang=zh_cn&edition=full","pubTime":"2026-10-07 18:23","pubTimestamp":1791368601,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年10月7日斥资26.02万港元回购3万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504259.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU2476274308.USD","LU2488822045.USD","02256","LU2778985437.USD","LU2476274720.SGD","IE00B543WZ88.USD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195011618","title":"和誉-B于10月7日回购3万股，耗资约26.02万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195011618","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195011618?lang=zh_cn&edition=full","pubTime":"2026-10-07 18:21","pubTimestamp":1791368506,"startTime":"0","endTime":"0","summary":"香港联交所上市公司和誉开曼有限责任公司于2026年10月7日发布公告，披露公司在香港联交所场内回购股份的最新情况。根据公告，和誉-B于10月7日回购了3万股普通股，占该次回购前公司已发行股本的约0.00419%。此次回购的最高价为每股8.885港元，最低价为每股8.59港元，合计支付约26.02万港元。截至目前，公司已累计回购1,854,000股，占购回授权决议获通过当日已发行股份总数约0.25877%。根据公告，本次回购相关信息由联席公司秘书张菡兮签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B于10月7日回购3万股，耗资约26.02万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673055458","title":"和誉-B(02256.HK)10月6日斥资36.16万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055458","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673055458?lang=zh_cn&edition=full","pubTime":"2026-10-06 19:39","pubTimestamp":1791286796,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","BK1161","LU2778985437.USD","IE00B543WZ88.USD","LU2476274308.USD","IE00BPRC5H50.USD","02256","LU2476274720.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194763837","title":"和誉-B：10月6日回购4.00万股股份，总额约36.16万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194763837","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194763837?lang=zh_cn&edition=full","pubTime":"2026-10-06 19:27","pubTimestamp":1791286059,"startTime":"0","endTime":"0","summary":"2026年10月6日，和誉开曼有限责任公司（下称“和誉-B”）发布翌日披露报表，披露于香港联交所场内回购了4.00万股股份，约占截至回购前公司已发行股本（不包括库藏股）约0.00558%。每股回购价格介乎每股8.90港元至9.23港元，合计支付约36.16万港元。回购完成后，公司已发行股本（不包括库藏股）变动为716,637,350股，库藏股数量增至9,568,000股，总股本为726,205,350股。\n公司已于2026年5月20日获得购回授权，总可回购股份数为71,646,135股。本次回购已遵照所有适用的上市规则及相关法律规定，并经公司董事会正式授权批准。公告由联席公司秘书张菡兮签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B：10月6日回购4.00万股股份，总额约36.16万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108623057","title":"和誉-B回购30,000股股份，涉资约26.38万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108623057","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108623057?lang=zh_cn&edition=full","pubTime":"2026-10-05 19:02","pubTimestamp":1791198124,"startTime":"0","endTime":"0","summary":"和誉-B于2026年10月5日于香港联交所场内回购普通股30,000股，占公司当日现有已发行股份约0.00419%。回购价格介乎每股8.765港元至8.855港元，合计支付约26.38万港元。回购后，公司已发行股份总数调整为716,677,350股；库藏股增加至9,528,000股，总股本维持在726,205,350股不变。本次回购基于2026年5月20日获得通过的购回授权开展，授权规模合计为71,646,135股。截至目前，公司依据该采购授权在港交所及其他证券交易所累计回购1,784,000股，占相关议案获通过当日已发行股份总数的约0.249%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和誉-B回购30,000股股份，涉资约26.38万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02256"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673704875","title":"和誉-B(02256)10月5日斥资26.4万港元回购3万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673704875","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673704875?lang=zh_cn&edition=full","pubTime":"2026-10-05 19:00","pubTimestamp":1791198044,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年10月5日斥资26.4万港元回购3万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503718.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B5MMRT66.SGD","BK1161","02256","LU2778985437.USD","IE00BPRC5H50.USD","LU2476274308.USD","IE00B543WZ88.USD","LU2476274720.SGD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672197987","title":"和誉-B(02256)10月2日斥资43.5万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2672197987","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672197987?lang=zh_cn&edition=full","pubTime":"2026-10-02 19:30","pubTimestamp":1790940620,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和誉-B(02256)发布公告，于2026年10月2日斥资43.5万港元回购5万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1503392.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","IE00B543WZ88.USD","LU2476274720.SGD","BK1161","IE00BPRC5H50.USD","02256","LU2476274308.USD","LU2778985437.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbisko.com","stockEarnings":[{"period":"1week","weight":-0.1077},{"period":"1month","weight":-0.2532},{"period":"3month","weight":-0.3555},{"period":"6month","weight":-0.4915},{"period":"1year","weight":-0.5221},{"period":"ytd","weight":-0.4685}],"compareEarnings":[{"period":"1week","weight":-0.0452},{"period":"1month","weight":-0.0701},{"period":"3month","weight":-0.0749},{"period":"6month","weight":-0.111},{"period":"1year","weight":-0.1107},{"period":"ytd","weight":-0.099}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和誉开曼有限责任公司是一家临床阶段生物制药公司。该公司致力于发现和开发创新差异化的小分子肿瘤疗法。该公司拥有两款核心候选产品ABSK011和 ABSK091，以及12款其他在研产品。ABSK011是一种强效且高选择性的成纤维细胞生长因子受体4(FGFR4) 小分子抑制剂。ABSK091 是一种分子靶向候选产品，也是 FGFR亚型 1、2和3的强效和选择性抑制剂。该公司的产品主要用于肝细胞癌(HCC)、尿路上皮癌(UC) 和胃癌(GC)。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.122249},{"month":2,"riseRate":0.8,"avgChangeRate":0.040621},{"month":3,"riseRate":0.4,"avgChangeRate":0.033777},{"month":4,"riseRate":0.4,"avgChangeRate":0.005698},{"month":5,"riseRate":0.2,"avgChangeRate":-0.025571},{"month":6,"riseRate":0.6,"avgChangeRate":0.025986},{"month":7,"riseRate":0.6,"avgChangeRate":0.025539},{"month":8,"riseRate":0.4,"avgChangeRate":0.067354},{"month":9,"riseRate":0.8,"avgChangeRate":0.036088},{"month":10,"riseRate":0.4,"avgChangeRate":-0.079638},{"month":11,"riseRate":0.6,"avgChangeRate":0.159978},{"month":12,"riseRate":0,"avgChangeRate":-0.092694}],"exchange":"SEHK","name":"和誉-B","nameEN":"ABBISKO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和誉-B,02256,和誉-B股票,和誉-B股票老虎,和誉-B股票老虎国际,和誉-B行情,和誉-B股票行情,和誉-B股价,和誉-B股市,和誉-B股票价格,和誉-B股票交易,和誉-B股票购买,和誉-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和誉-B(02256)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和誉-B(02256)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}